Hajime Nakamura

Hajime Nakamura

Auto-generated profile, based on publicly available information

Hajime Nakamura

Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
SOShuhei Okazaki
Shuhei Okazaki
TYTakeshi Yoshimoto
Takeshi Yoshimoto
MOMariko Ohara
Mariko Ohara
MTMasatoshi Takagaki
Masatoshi Takagaki
HNHajime Nakamura
Hajime Nakamura
HMHideki Mochizuki
Hideki Mochizuki
Background and Objectives Intracranial artery stenosis is the predominant etiology of ischemic stroke in the Asian population. Furthermore, the presence of the RNF213 p.R4810K variant, which is a susceptibility gene for moyamoya disease, increases the risk of ischemic stroke attributable to large-artery atherosclerosis. Accordingly, we hypothesized that this genetic variant may affect the long-term outcome of intracranial artery stenosis in the East Asian population. We thus aimed to examine the effect of this variant on the long-term progression and prognosis of intracranial artery stenosis. Methods Using a prospective database, we identified adult patients with intracranial artery stenosis who underwent periodic MRI examinations for >5 years. We evaluated stenosis progression using a validated visual grading system. We excluded patients diagnosed with moyamoya disease at the time of initial MRI. Genotyping of RNF213 p.R4810K was performed at the end of the follow-up period. Results Among 52 eligible patients, 22 (42%) were carriers of the RNF213 p.R4810K variant. The median follow-up duration was 10.3 years. During the follow-up period, progression of intracranial artery stenosis was observed in 64% variant carriers and 27% noncarriers. There was a significant association of the variant with time to progression of intracranial artery stenosis (hazard ratio [HR] 3.31, 95% CI 1.38–7.90, p = 0.007), and time to the composite endpoint of symptomatic stroke and transient ischemic attack (HR 3.70, 95% CI 1.15–11.86, p = 0.028), but not to symptomatic stroke alone (HR 2.18, 95% CI 0.62–7.74, p = 0.23). Two variant carriers with progression were newly diagnosed with moyamoya disease. Discussion Our findings indicated that the RNF213 p.R4810K variant increases the risk of intracranial artery stenosis progression.

1 January 2019 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
HNHajime Nakamura
Hajime Nakamura
TFToshiyuki Fujinaka
Toshiyuki Fujinaka
TNTakeo Nishida
Takeo Nishida
HKHaruhiko Kishima
Haruhiko Kishima
NSNobuyuki Sakai
Nobuyuki Sakai
JGJR-NET3 study group
JR-NET3 study group
Ruptured vertebral artery dissecting aneurysm (VADA) causes subarachnoid hemorrhage (SAH), and parent artery occlusion (PAO) with endovascular technique (EVT) has been the first-line treatment for ruptured VADA. In this study, we have extracted 530 ruptured VADA, treated through PAO with EVT, from a nationwide, retrospective, multi-center registration in Japan (JR-NET3), and analyzed factors associated with outcome at 30 days and procedure-related complications. Complete occlusion was achieved in 497 cases (93.8%) and favorable outcome was obtained in 303 cases (59.1%). Older age (≥60 years), male sex, use of general anesthesia, non-specialist as the responsible doctor, and time delay from onset to treatment (≥24 h) were negative factors for favorable outcome in multivariate analysis, although these factors were not associated with procedure-related complications. Compared with previous studies (JR-NET1 and 2), the number of endovascular treatments for patients with VADA and severe SAH increased in this decade; however, the percentage of patients with favorable outcome did not decrease. This might be due to not only the improvement of endovascular treatment itself, but also increased access to endovascular specialists or standardization of management.

18 March 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
YMYuichi Matsui
Yuichi Matsui
FMFumitaka Muramatsu
Fumitaka Muramatsu
HNHajime Nakamura
Hajime Nakamura
YNYoshimi Noda
Yoshimi Noda
KMKinnosuke Matsumoto
Kinnosuke Matsumoto
NTNobuyuki Takakura
Nobuyuki Takakura
Whether organ-specific regeneration is induced by organ-specific endothelial cells (ECs) remains unelucidated. The formation of white matter lesions due to chronic cerebral hypoperfusion causes cognitive decline, depression, motor dysfunction, and even acute ischemic stroke. Vascular ECs are an important target for treating chronic cerebral hypoperfusion. Brain-derived ECs transplanted into a mouse chronic cerebral hypoperfusion model showed excellent angiogenic potential. They were also associated with reducing both white matter lesions and brain dysfunction possibly due to the high expression of neuroprotective humoral factors. The in vitro coculture of brain cells with ECs from several diverse organs suggested the function of brain-derived endothelium is affected within a brain environment due to netrin-1 and Unc 5B systems. We found brain CD157-positive ECs were more proliferative and beneficial in a mouse model of chronic cerebral hypoperfusion than CD157-negative ECs upon inoculation. We propose novel methods to improve the symptoms of chronic cerebral hypoperfusion using CD157-positive ECs.

1 January 2022 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
NKNobuo Kashiwagi
Nobuo Kashiwagi
KMKoichi Miyazaki
Koichi Miyazaki
HTHiroto Takahashi
Hiroto Takahashi
KTKiyoshi Tsuji
Kiyoshi Tsuji
MFMasahiro Fujiwara
Masahiro Fujiwara
NTNoriyuki Tomiyama
Noriyuki Tomiyama

8 August 2023 in Clinical Neuroradiology
Verified
Journal Article
Open access
PDF file
MHMasafumi Hiramatsu
Masafumi Hiramatsu
TOTomohiko Ozaki
Tomohiko Ozaki
STShuichi Tanoue
Shuichi Tanoue
KMKatsuhiro Mizutani
Katsuhiro Mizutani
HNHajime Nakamura
Hajime Nakamura
HKHiro Kiyosue
Hiro Kiyosue
Background and Purpose: There has been limited literature regarding the bridging veins (BVs) of the medulla oblongata around the foramen magnum (FM). The present study aims to analyze the normal angioarchitecture of the BVs around the FM using slab MIP images of three-dimensional (3D) angiography. Methods: We collected 3D angiography data of posterior fossa veins and analyzed the BVs around the FM using slab MIP images. We analyzed the course, outlet, and number of BVs around the FM. We also examined the detection rate and mean diameter of each BV. Results: Of 57 patients, 55 patients (96%) had any BV. The median number of BVs was two (range: 0–5). The BVs originate from the perimedullary veins and run anterolaterally to join the anterior condylar vein (ACV), inferior petrosal sinus, sigmoid sinus, or jugular bulb, inferolaterally to join the suboccipital cavernous sinus (SCS), laterally or posterolaterally to join the marginal sinus (MS), and posteriorly to join the MS or occipital sinus. We classified BVs into five subtypes according to the draining location: ACV, jugular foramen (JF), MS, SCS, and cerebellomedullary cistern (CMC). ACV, JF, MS, SCS, and CMC BVs were detected in 11 (19%), 18 (32%), 32 (56%), 20 (35%), and 16 (28%) patients, respectively. The mean diameter of the BVs other than CMC was 0.6 mm, and that of CMC BV was 0.8 mm. Conclusion: Using venous data from 3D angiography, we detected FM BVs in most cases, and the BVs were connected in various directions.

27 June 2019 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
TMT. Murakami
T. Murakami
TNT. Nishida
T. Nishida
KAK. Asai
K. Asai
YKY. Kadono
Y. Kadono
HNH. Nakamura
H. Nakamura
HKH. Kishima
H. Kishima
BACKGROUND AND PURPOSE: The appropriate period of follow-up examinations after endovascular embolization for cerebral aneurysms using time-of-flight MR angiography is not well-known. We retrospectively investigated long-term results after endovascular embolization for unruptured cerebral aneurysms and evaluated the periods from embolization to recanalization and retreatment. MATERIALS AND METHODS: Between April 2006 and March 2011, one hundred forty-eight unruptured aneurysms were treated with endovascular coil embolization. Among them, we investigated 116 unruptured aneurysms, which were followed up for >5 years. Time-of-flight MR angiography was performed at 1 day, 3–6 months, 1 year after the procedure, and every year thereafter. RESULTS: The mean follow-up period was 7.0 ± 1.4 years. Recanalization was observed in 19 (16.3%) aneurysms within 2 years. Among them, retreatment for recanalization was performed in 8 (6.8%) aneurysms. No recanalization was detected in any aneurysms that had been stable in the first 2 years after embolization. A larger maximum aneurysm size was significantly correlated with recanalization (P = .019). CONCLUSIONS: Aneurysms in which recanalization was not observed within 2 years after endovascular coil embolization were stable during a mean follow-up of 7 years. This result may be helpful in considering the appropriate span or frequency of follow-up imaging for embolized cerebral aneurysms.